0 458

Cited 31 times in

CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods

DC Field Value Language
dc.contributor.author김형범-
dc.contributor.author호사발레랑가파바라티-
dc.date.accessioned2018-03-26T16:56:03Z-
dc.date.available2018-03-26T16:56:03Z-
dc.date.issued2015-
dc.identifier.issn0304-419X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/156977-
dc.description.abstractWhile human gene therapy has gained significant attention for its therapeutic promise, CRISPR/Cas9 technology has made a breakthrough as an efficient genome editing tool by emulating prokaryotic immune defense mechanisms. Although many studies have found that CRISPR/Cas9 technology is more efficient, specific and manipulable than previous generations of gene editing tools, it can be further improved by elevating its overall efficiency in a higher frequency of genome modifications and reducing its off-target effects. Here, we review the development of CRISPR/Cas9 technology, focusing on enhancement of its sequence specificity, reduction of off-target effects and delivery systems. Moreover, we describe recent successful applications of CRISPR/Cas9 technology in laboratory and clinical studies.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Pub. Co.-
dc.relation.isPartOfBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHBase Sequence-
dc.subject.MESHCRISPR-Associated Proteins/genetics*-
dc.subject.MESHCRISPR-Cas Systems/genetics*-
dc.subject.MESHClustered Regularly Interspaced Short Palindromic Repeats/genetics*-
dc.subject.MESHDNA/genetics*-
dc.subject.MESHGenetic Engineering/methods*-
dc.subject.MESHMolecular Sequence Data-
dc.subject.MESHReproducibility of Results-
dc.subject.MESHSensitivity and Specificity-
dc.subject.MESHTransfection/methods*-
dc.titleCRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Pharmacology-
dc.contributor.googleauthorYoung-Il Jo-
dc.contributor.googleauthorBharathi Suresh-
dc.contributor.googleauthorHyongbum Kim-
dc.contributor.googleauthorSuresh Ramakrishna-
dc.identifier.doi10.1016/j.bbcan.2015.09.003-
dc.contributor.localIdA01148-
dc.contributor.localIdA04705-
dc.relation.journalcodeJ02904-
dc.identifier.eissn1878-2434-
dc.identifier.pmid26434948-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0304419X15000700-
dc.subject.keywordCRISPR/Cas9 applications-
dc.subject.keywordDelivery methods-
dc.subject.keywordGenome editing-
dc.subject.keywordReduced off-target effects-
dc.subject.keywordSequence specificity-
dc.subject.keywordTherapeutics-
dc.contributor.alternativeNameKim, Hyongbum-
dc.contributor.alternativeNameRamakrishna, S-
dc.contributor.affiliatedAuthorKim, Hyongbum-
dc.contributor.affiliatedAuthorRamakrishna, S-
dc.citation.volume1856-
dc.citation.number2-
dc.citation.startPage234-
dc.citation.endPage243-
dc.identifier.bibliographicCitationBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, Vol.1856(2) : 234-243, 2015-
dc.identifier.rimsid41286-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.